检索结果-内蒙古大学图书馆

The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review

引用

PREVENTIVE MEDICINE REPORTS 2024年 44卷 102778-102778页

作者： Seyedalinaghi, Seyedahmad Dashti, Mohsen Afzalian, Arian Siami, Haleh Ghasemzadeh, Afsaneh Varshochi, Sanaz Parikhani, Sahar Nooralioghli Amrollah, Masoomeh Fathi Nourian, Anahid Mehraeen, Esmaeil dadras, omid Univ Tehran Med Sci Iranian Inst Reduct High Risk Behav Iranian Res Ctr HIV AIDS Tehran Iran Tabriz Univ Med Sci Dept Radiol Tabriz Iran Univ Tehran Med Sci Sch Med Tehran Iran Islamic Azad Univ Sch Med Tehran Iran Univ Tehran Med Sci Fac Pharm Dept Pharmacotherapy Tehran Iran Khalkhal Univ Med Sci Dept Hlth Informat Technol Khalkhal *** Iran

Introduction: This study examines the efficacy and safety of three COVID-19 booster vaccines including mRNAbased vaccines (BNT162b2 (BioNTech/Pfizer) and/or mRNA-1273 (Moderna)), Non-Replicating Viral-Vector vaccines (ChAdOx1 nCoV-19 vaccine (AstraZeneca) and/or Ad26. COV2.S (Johnson & Johnson)), and Protein Subunit vaccine (SpikoGen) in immunosuppressed patients. Methods: Relevant articles were systematically searched using medical subject heading (MeSH) and keywords "COVID-19" and "booster dose" or "booster vaccine" or ''fourth dose" in the online databases of PubMed, Embase, Scopus, and Web of Science. To identify eligible studies, a two-phase screening process was implemented. Initially, three researchers evaluated the studies based on the relevancy of the title and abstract. Results: A total of 58 studies met the inclusion criteria and were included in this review. The findings suggest that booster doses offer greater protection against the disease than the primary dose. The study also compared various vaccine types, revealing that viral vector and nucleic acid vaccines outperformed inactivated vaccines. Results indicated that individuals receiving booster doses experienced superior outcomes compared to those without boosters. Vaccination against COVID-19 emerged as the most effective preventive measure against infection and symptom severity. Elevated antibody levels post -booster dose vaccination in the population signaled robust immune responses, underscoring the benefits of supplementary vaccine doses. Conclusion: This systematic review highlights preliminary evidence supporting the immunologic outcomes and safety of COVID-19 vaccine boosters in enhancing immune responses against SARS-CoV-2. However, further research is needed to determine optimal timing intervals between primary vaccination series and boosters while considering global equity issues and variant-specific considerations.

关键词： COVID-19 SARS-CoV-2 Booster dose Adverse events Immunologic outcomes Immunogenicity

来源：评论

学校读者我要写书评

暂无评论

Reinfection risk of novel coronavirus(COVID-19):A systematic review of current evidence

引用

World Journal of Virology 2020年第5期9卷 79-90页

作者： SeyedAhmad SeyedAlinaghi Shahram Oliaei Shaghayegh Kianzad Amir Masoud Afsahi Mehrzad MohsseniPour Alireza Barzegary Pegah Mirzapour Farzane Behnezhad Tayebeh Noori Esmaeil Mehraeen omid dadras Fabricio Voltarelli Jean-Marc Sabatier Iranian Research Center for HIV/AIDS Iranian Institute for Reduction of High Risk BehaviorsTehran University of Medical SciencesTehran ***Iran HBOT Research Center Golestan HospitalIslamic Republic of IranNavy and AJA Medical UniversityTehran ***Iran School of Medicine Iran University of Medical SciencesTehran ***Iran Department of Radiology School of MedicineUniversity of CaliforniaSan Diego(UCSD)CaliforniaCA 587652458United States School of Medicine Islamic Azad UniversityTehran ***Iran Department of Virology School of Public HealthTehran University of Medical SciencesTehran ***Iran Department of Health Information Technology Zabol University of Medical SciencesZabol ***Iran Department of Health Information Technology Khalkhal University of Medical SciencesKhalkhal ***Iran Department of Global Health and Socioepidemiology Graduate School of MedicineKyoto UniversityKyoto 215789652Japan Graduation Program of Health Sciences Faculty of MedicineFederal University of Mato GrossoCuiaba 458796523Brazil UniversitéAix-Marseille Institutde Neuro-physiopathologie(INP)UMR 7051Facultéde Pharmacie27 Bd Jean MoulinMarseille 546789235France

BACKGROUND There is recently a concern regarding the reinfection and reactivation of previously reCoVered coronavirus disease 2019(CoVID-19)*** To summarize the recent findings and reports of CoVID-19 reinfection in patients previously reCoVered from the *** This study was a systematic review of current evidence conducted in August *** authors studied the probable reinfection risk of novel coronavirus(CoVID-19).We performed a systematic search using the keywords in online *** investigation adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA)checklist to ensure the reliability and validity of this study and *** We reviewed 31 *** studies described reCoVered patients with *** one study reported reinfected patients who *** 26 studies,there was no information about the status of the *** studies indicated that reinfection is not probable and that post-infection immunity is at least temporary and *** Based on our review,we concluded that a positive polymerase chain reaction retest could be due to several reasons and should not always be considered as reinfection or reactivation of the *** relevant studies in positive retest patients have shown relative and probably temporary immunity after the reCoVery of the disease.

关键词： Reactivation Reinfection Postinfection Coronavirus CoVID-19 SARSCoV-2

来源：评论

学校读者我要写书评

暂无评论

The effect of macronutrient and micronutrient supplements on COVID-19: an umbrella review

引用

JOURNAL OF HEALTH POPULATION AND NUTRITION 2024年第1期43卷 1页

作者： Seyedalinaghi, Seyedahmad Shahidi, Ramin Mojdeganlou, Hengameh Akhtaran, Fatemeh Khajeh Maroufi, Seyed Farzad Maroufi, Seyede Parmis Mirzapour, Pegah Karimi, Amirali Khodaei, Sepideh Pour, Mehrzad Mohsseni Mehraeen, Esmaeil dadras, omid Univ Tehran Med Sci Iranian Inst Reduct High Risk Behav Iranian Res Ctr HIV AIDS Tehran Iran Bushehr Univ Med Sci Sch Med Bushehr Iran Johns Hopkins Univ Sch Med Dept Pathol Baltimore MD USA Shahid Beheshti Univ Fac Math Sci Social & Econ Stat Tehran Iran Univ Tehran Med Sci Sch Med Tehran Iran Semnan Univ Med Sci Fac Med Semnan Iran Khalkhal Univ Med Sci Dept Hlth Informat Technol Khalkhal *** Iran Haukeland Hosp Dept Addict Med Bergen Addict Res Bergen Norway

Background and aimsA healthy diet play an important role in the prevention and even treatment of various diseases. Proper nutrition plays an important role in boosting of immune system. These include the consumption of macronutrients such as proteins, lipids, carbohydrates, and also micronutrients including vitamins. Here, we aimed to systematically review the effects of macronutrients and micronutrients on the prevention and treatment of *** searched the databases of PubMed, Scopus, Embase, and Web of Science on December 23, 2023. The records were downloaded into an EndNote file, the duplicates were removed, and the studies underwent a two-phase screening process based on their title/abstracts and full texts. The included articles were screened and underwent inclusion and exclusion criteria. We included the English systematic reviews and meta-analyses that concurred with the aim of our study. The selected articles were assessed by Cochrane's Risk of Bias in Systematic Reviews for the quality check. The data of the eligible studies were extracted in a pre-designed word table and were used for the qualitative *** total of 28 reviews were included in this study. Most studies have shown that micronutrients are effective in morbidity and mortality controlling in viral respiratory infections such as COVID-19 but some studies have shown that micronutrients are sometimes not effective in controlling severity. On the other hand, calcifediol was by far the most successful agent in reducing intensive care needs and mortality between *** without malnutrition had a reduced risk of SARS-CoV-2 infection and severe disease. The administration of Vitamin D is effective in reducing the morbidity and mortality of COVID-19 patients. Patients with vitamin D deficiency were more prone to experience severe infection, and they were at higher risk of morbidities and mortality. Other micronutrients such as Vitamin A, Vitamin B, and Zin

关键词： COVID-19 Macronutrients Micronutrients Nutrition Nutrients SARS-CoV-2

来源：评论

学校读者我要写书评

暂无评论

Public acceptability of COVID-19 vaccines and its predictors in Middle left-to-right markEastern/North African (MENA) countries: a systematic reviewleft-to-right mark

引用

HUMAN VACCINES & IMMUNOTHERAPEUTICS 2022年第5期18卷 Article: 2043719页

作者： dadras, omid SeyedAlinaghi, SeyedAhmad Karimi, Amirali Shamsabadi, Ahmadreza Mahdiabadi, Sara Mohammadi, Parsa Amiri, Ava Shojaei, Alireza Pashaei, Zahra Mirzapour, Pegah Qaderi, Kowsar MohsseniPour, Mehrzad Alilou, Sanam Mehraeen, Esmaeil Jahanfar, Shayesteh Walailak Univ Sch Publ Hlth Nakhon Si Thammarat Thailand Univ Tehran Med Sci Iranian Res Ctr HIV AIDS Iranian Inst Reduct High Risk Behav Tehran Iran Univ Tehran Med Sci Sch Med Tehran Iran Esfarayen Fac Med Sci Dept Hlth Informat Technol Esfarayen Iran Kermanshah Univ Med Sci Sch Nursing & Midwifery Dept Midwifery Kermanshah Iran Khalkhal Univ Med Sci Dept Hlth Informat Technol Khalkhal Iran Tufts Univ Sch Med MPH Program Dept Publ Hlth & Community Med Boston MA 02111 USA

Introduction COVID-19 vaccines emerged as a worldwide hope to contain the pandemic. However, many people left-to-right markare still hesitant to receive these vaccines. We aimed to systematically review the public knowledge, perception, and acceptability of COVID-19 vaccines in the Middle East and North Africa (MENA) countries and the predictors of vaccine acceptability in this region. Methods We systematically searched databases of PubMed, Scopus, Web of Science, and Cochrane and retrieved left-to-right markall relevant studies by 5 August 2021. Results There was a considerable variation in the COVID-19 vaccine acceptance left-to-right markrates, from 12% in a study from Israel to 83.3% in Kuwait, although two other studies from Israel mentioned 75% left-to-right markand 82.2% acceptability rates. Concerns about the side effects and safety of the vaccine were the main reasons for left-to-right markthe lack of acceptability of taking the vaccine, which was reported in 19 studies. left-to-right mark Conclusion Several factors, such as age, gender, education level, and comorbidities, left-to-right markare worthy of attention as they could expand vaccine coverage in the target ***-to-right mark

关键词： Attitude acceptability COVID-19 COVID-19 vaccine Middle East North Africa perception SARS-CoV-2 vaccine

来源：评论

学校读者我要写书评

暂无评论

Burden of Disease Attributable to Pm2.5 at Low Exposure Levels: Impact of Methodological Choices

SSRN

引用

SSRN 2024年

作者： Lehtomäki, Heli Aasvang, Gunn Marit Sulo, Gerhard Denby, Bruce R. Hänninen, Otto Olavi Brauer, Michael Pereira, Gavin dadras, omid Bølling, Anette Kocbach Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland Faculty of Health Sciences University of Eastern Finland Kuopio Finland Department of Air Quality and Noise Norwegian Institute of Public Health Oslo Norway Division for Climate Modelling and Air Pollution Norwegian Meteorological Institute Oslo Norway School of Population and Public Health University of British Columbia VancouverBC Canada Institute for Health Metrics and Evaluation University of Washington SeattleWA United States School of Population Health Curtin University BentleyWA Australia Centre for Fertility and Health Norwegian Institute of Public Health Oslo Norway Department of Global Public Health and Primary Care University of Bergen Bergen Norway Tehran University of Medical Sciences Tehran Iran

关键词： Air pollution

来源：评论

学校读者我要写书评

暂无评论

Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021

引用

The Lancet 2025年第10482期405卷 897-910页

作者： Bernabe, Eduardo Marcenes, Wagner Abdulkader, Rizwan Suliankatchi Abreu, Lucas Guimarães Afzal, Saira Alhalaiqa, Fadwa Naji Al-Maweri, Sadeq Alsharif, Ubai Anyasodor, Anayochukwu Edward Arora, Amit Asgary, Saeed Ashraf, Tahira Balasubramanian, Madhan Banakar, Morteza Barrow, Amadou Bashiri, Azadeh Belay, Sefealem Assefa Belgaumi, Uzma Iqbal Berhie, Alemshet Yirga Bhardwaj, Pankaj Bhaskar, Sonu Bijani, Ali Bouaoud, Souad Cao, Yin Chaurasia, Akhilanand Chen, Meng Xuan Chu, Dinh-Toi Cruz-Martins, Natalia dadras, omid Dai, Xiaochen Diaz, Daniel Du, Mi Ekholuenetale, Michael Ekundayo, Temitope Cyrus El Tantawi, Maha Elhadi, Muhammed Fagbamigbe, Adeniyi Francis Farshidfar, Nima Fatehizadeh, Ali Fischer, Florian Folayan, Morenike Oluwatoyin Gaewkhiew, Piyada Gajdács, Márió Golechha, Mahaveer Gupta, Bhawna Gupta, Sapna Hagins, Hailey Halboub, Esam S Hamidi, Samer Hariyani, Ninuk Hay, Simon I Heidari, Mohammad Herrera-Serna, Brenda Yuliana Heyi, Demisu Zenbaba Hostiuc, Sorin Humphrey, Kyle Matthew Ibitoye, Segun Emmanuel Ilic, Milena D Isola, Gaetano Kandaswamy, Eswar Kantar, Rami S Kaur, Navjot Kemmer, Laura Khader, Yousef Saleh Khateri, Sorour Kisa, Adnan Krishan, Kewal Kruger, Estie Lalloo, Ratilal Li, An Lim, Stephen S Mestrovic, Tomislav Mokdad, Ali H Moreira, Rafael Silveira Morrison, Shane Douglas Murray, Christopher J L Natto, Zuhair S Nayak, Biswa Prakash Nguyen, Trang Nguyen, Van Thanh Omotayo, Abiodun Olusola Padron-Monedero, Alicia Patel, Jay Patil, Shankargouda Pawar, Shrikant Petcu, Ionela-Roxana Qattea, Ibrahim Rahman, Mosiur Ratan, Zubair Ahmed Riad, Abanoub S, Manjula S N, Chandan Sabour, Siamak Saheb Sharif-Askari, Fatemeh Sahebkar, Amirhossein Sakshaug, Joseph W Samy, Abdallah M Sarode, Sachin C Sawhney, Monika Schwendicke, Falk Shaikh, Masood Ali Tadakamadla, Santosh Kumar Tesler, Riki Thiyagarajan, Arulmani Tovani-Palone, Marcos Roberto Umair, Muhammad Unnikrishnan, Bhaskaran Valadan Tahbaz, Sahel Varma, Siddhartha Alluri Vukovic, Ana Petar Wang, Cong Wickramasinghe, Nuwan Darshana Yadav, Lalit Yiğit,

Background: The WHO Global Oral Health Action Plan has set an overarching global target of achieving a 10% reduction in the prevalence of oral conditions by 2030. Robust and up-to-date information on the global burden of oral conditions is paramount to monitor progress towards this target. The aim of this systematic data analysis was to produce global, WHO region, and country-level estimates of the prevalence of, and disability-adjusted life-years (DALYs) attributed to, untreated caries, severe periodontitis, edentulism, other oral disorders, lip and oral cavity cancer, and orofacial clefts from 1990 to 2021. Methods: This report is based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. Input data were extracted from epidemiological surveys, population-based registries, and vital statistics. Data were modelled with DisMod-MR 2.1, a Bayesian meta-regression modelling tool, to ensure consistency between prevalence, incidence, remission, and mortality estimates for oral conditions. DALYs were estimated as the aggregation of the years of life lost (YLLs) due to premature mortality and years lived with disability (YLDs). YLDs were calculated by multiplying prevalence estimates, the severity of the oral condition's sequelae (disability weight) and duration of the sequelae. Although all oral conditions lead to YLDs, only lip and oral cavity cancer and orofacial clefts lead to YLLs as well. 95% uncertainty intervals (UIs) were generated for every metric with the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: The combined global age-standardised prevalence of the main oral conditions (untreated caries, severe periodontitis, edentulism, and other oral disorders) was 45 900 (95% UI 42 300 to 49 800) per 100 000 population in 2021, with 3·69 billion (3·40 to 4·00) people affected globally. Untreated dental caries of permanent teeth and severe periodontitis were the most common oral conditions, with a global age-sta

关键词：

来源：评论

学校读者我要写书评

暂无评论

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

引用

EUROPEAN JOURNAL OF MEDICAL RESEARCH 2021年第1期26卷 51-51页

作者： SeyedAlinaghi, SeyedAhmad Mirzapour, Pegah dadras, omid Pashaei, Zahra Karimi, Amirali MohsseniPour, Mehrzad Soleymanzadeh, Mahdi Barzegary, Alireza Afsahi, Amir Masoud Vahedi, Farzin Shamsabadi, Ahmadreza Behnezhad, Farzane Saeidi, Solmaz Mehraeen, Esmaeil Jahanfar, Shayesteh Univ Tehran Med Sci Iranian Inst Reduct High Risk Behav Iranian Res Ctr HIV AIDS Tehran Iran Kyoto Univ Grad Sch Med Dept Global Hlth & Socioepidemiol Kyoto Japan Masih Daneshvari Hosp Chron Resp Dis Res Ctr Tehran Iran Univ Tehran Med Sci Sch Med Tehran Iran Univ Tehran Med Sci Sch Med Farabi Hosp Tehran Iran Islamic Azad Univ Sch Med Tehran Iran Univ Calif San Diego Dept Radiol Sch Med San Diego CA 92103 USA Esfarayen Fac Med Sci Dept Hlth Informat Technol Esfarayen Iran Univ Tehran Med Sci Sch Publ Hlth Dept Virol Tehran Iran Khalkhal Univ Med Sci Dept Nursing Khalkhal Iran Khalkhal Univ Med Sci Dept Hlth Informat Technol Khalkhal *** Iran Tufts Univ Sch Med Dept Publ Hlth & Community Med Boston MA 02111 USA

Introduction Coronavirus Disease-2019 (SARS-CoV-2) started its devastating trajectory into a global pandemic in Wuhan, China, in December 2019. Ever since, several variants of SARS-CoV-2 have been identified. In the present review, we aimed to characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality. Methods A systematic review including the current evidence related to different variants of SARS-CoV-2 and the related morbidity and mortality was conducted through a systematic search utilizing the keywords in the online databases including Scopus, PubMed, Web of Science, and Science Direct;we retrieved all related papers and reports published in English from December 2019 to September 2020. Results A review of identified articles has shown three main genomic variants, including type A, type B, and type C. we also identified three clades including S, V, and G. Studies have demonstrated that the C14408T and A23403G alterations in the Nsp12 and S proteins are the most prominent alterations in the world, leading to life-threatening *** spike D614G amino acid change has become the most common variant since December 2019. From missense mutations found from Gujarat SARS-CoV-2 genomes, C28854T, deleterious mutation in the nucleocapsid (N) gene was significantly associated with patients' mortality. The other significant deleterious variant (G25563T) is found in patients located in Orf3a and has a potential role in viral pathogenesis. Conclusion Overall, researchers identified several SARS-CoV-2 variants changing clinical manifestations and increasing the transmissibility, morbidity, and mortality of COVID-19. This should be considered in current practice and interventions to combat the pandemic and prevent related morbidity and mortality.

关键词： Variants Strains Genomic diversity Characterizations SARS-CoV-2 COVID-19

来源：评论

学校读者我要写书评

暂无评论

Genetic susceptibility of COVID-19: a systematic review of current evidence

引用

EUROPEAN JOURNAL OF MEDICAL RESEARCH 2021年第1期26卷 46-46页

作者： SeyedAlinaghi, SeyedAhmad Mehrtak, Mohammad MohsseniPour, Mehrzad Mirzapour, Pegah Barzegary, Alireza Habibi, Pedram Moradmand-Badie, Banafsheh Afsahi, Amir Masoud Karimi, Amirali Heydari, Mohammad Mehraeen, Esmaeil dadras, omid Sabatier, Jean-Marc Voltarelli, Fabricio Univ Tehran Med Sci Iranian Res Ctr HIV AIDS Iranian Inst Reduct High Risk Behav Tehran Iran Ardabil Univ Med Sci Sch Med & Allied Med Sci Healthcare Serv Management Ardebil Iran Islamic Azad Univ Sch Med Tehran Iran Univ New South Wales Black Dog Inst Sydney NSW Australia Univ Calif San Diego Sch Med Dept Radiol San Diego CA USA Univ Tehran Med Sci Sch Med Tehran Iran Khalkhal Univ Med Sci Dept Hlth Informat Technol Khalkhal *** Iran Kyoto Univ Grad Sch Med Dept Global Hlth & Socioepidemiol Kyoto Japan Univ Aix Marseille Fac Pharm Inst Neurophysiopathol INP UMR 7051 27 Bd Jean Moulin F-13385 Marseille France Univ Fed Mato Grosso Fac Med Grad Program Hlth Sci Cuiaba Brazil

Introduction While COVID-19 pandemic continues to spread worldwide, researchers have linked patterns of traits to poor disease outcomes. Risk factors for COVID-19 include asthma, elderly age, being pregnant, having any underlying diseases such as cardiovascular disease, diabetes, obesity, and experiencing lifelong systemic racism. Recently, connections to certain genes have also been found, although the susceptibility has not yet been established. We aimed to investigate the available evidence for the genetic susceptibility to COVID-19. Methods This study was a systematic review of current evidence to investigate the genetic susceptibility of COVID-19. By systematic search and utilizing the keywords in the online databases including Scopus, PubMed, Web of Science, and Science Direct, we retrieved all the related papers and reports published in English from December 2019 to September 2020. Results According to the findings, COVID-19 uses the angiotensin-converting enzyme 2 (ACE2) receptor for cell entry. Previous studies have shown that people with ACE2 polymorphism who have type 2 transmembrane serine proteases (TMPRSS2) are at high risk of SARS-CoV-2 infection. Also, two studies have shown that males are more likely to become infected with SARS-CoV-2 than females. Besides, research has also shown that patients possessing HLA-B*15:03 genotype may become immune to the infection. Conclusion Combing through the genome, several genes related to immune system's response were related to the severity and susceptibility to the COVID-19. In conclusion, a correlation was found between the ACE2 levels and the susceptibility to SARS-CoV-2 infection.

关键词： Genetic susceptibility Genetic vulnerability Genetic probability COVID-19 SARS-CoV-2

来源：评论

学校读者我要写书评

暂无评论

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review

引用

EUROPEAN JOURNAL OF MEDICAL RESEARCH 2021年第1期26卷 96-96页

作者： Oliaei, Shahram Alinaghi, Seyed Ahmad Seyed Mehrtak, Mohammad Karimi, Amirali Noori, Tayebeh Mirzapour, Pegah Shojaei, Alireza MohsseniPour, Mehrzad Mirghaderi, Seyed Peyman Alilou, Sanam Shobeiri, Parnian Cheshmekabodi, Hadiseh Azadi Mehraeen, Esmaeil dadras, omid Navy & AJA Med Univ Golestan Hosp HBOT Res Ctr Tehran Iran Tehran Uni Med Sci Iranian Inst Reduct High Risk Behav Iranian Res Ctr HIV AIDS Tehran Iran Ardabil Univ Med Sci Sch Med & Allied Med Sci Healthcare Serv Management Ardebil Iran Univ Tehran Med Sci Sch Med Tehran Iran Zabol Univ Med Sci Dept Hlth Informat Technol Zabol Iran Iran Univ Med Sci Sch Hlth Informat Management & Informat Sci Hlth Informat Technol Tehran Iran Supreme Natl Def Univ AMAD Res Inst Tehran Iran Khalkha Univ Med Sci Dept Hlth Informat Technol Khalkha *** Iran Kyoto Univ Grad Sch Med Dept Global Hlth & Socioepidemiol Kyoto Japan

Background Oxygenation serves as a cornerstone in the treatment of COVID-19, and several methods have been extensively studied so far. Herein, we aimed to systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19. Methods We systematically searched and retrieved the relevant articles using keywords on the online databases, including PubMed, Scopus, Embase, Web of Science, and Cochrane databases up to April 11th, 2021. The retrieved records underwent a two-step title/abstract and full-text screening process, and the eligible papers were identified. National Institutes of health (NIH) quality assessment tool was used for this study. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) with ID CRD42021269821. Results Eight articles from three countries were included. All the included studies had good and fair quality scores, with no poor studies included in this systematic review (Good: n = 5, Fair: n = 3). Studies were divided into clinical trials and case reports/series. Most of the studies used HBOT less than 1.5-2 absolute atmospheres (ATA) for 90 min sessions and thereafter sessions were decreased to 60 min. Trials demonstrated most of the patients recovered after receiving HBOT, and blood oxygen saturation increased after several sessions of HBOT. Conclusion Overall, HBOT seems to be a safe and effective oxygenation method in patients with COVID-19. However, there is limited knowledge and evidence regarding the effects and mechanism of HBOT in COVID-19 treatment, and further evaluations require extensive well-designed studies.

关键词： COVID-19 Hyperbaric oxygenation Hyperbaric oxygen therapy SARS-CoV-2

来源：评论

学校读者我要写书评

暂无评论

Effects of COVID-19 prevention procedures on other common infections: a systematic review

引用

EUROPEAN JOURNAL OF MEDICAL RESEARCH 2021年第1期26卷 67-67页

作者： dadras, omid Alinaghi, Seyed Ahmad Seyed Karimi, Amirali MohsseniPour, Mehrzad Barzegary, Alireza Vahedi, Farzin Pashaei, Zahra Mirzapour, Pegah Fakhfouri, Amirata Zargari, Ghazal Saeidi, Solmaz Mojdeganlou, Hengameh Badri, Hajar Qaderi, Kowsar Behnezhad, Farzane Mehraeen, Esmaeil Walailak Univ Sch Publ Hlth Nakhon Si Thammarat Thailand Univ Tehran Med Sci Iranian Inst Reduct High Risk Behav Iranian Res Ctr HIV AIDS Tehran Iran Univ Tehran Med Sci Sch Med Tehran Iran Islamic Azad Univ Sch Med Tehran Iran Iran Univ Med Sci Sch Med Tehran Iran Khalkhal Univ Med Sci Dept Nursing Khalkhal Iran Urmia Univ Med Sci Dept Pathol Orumiyeh Iran Guilan Univ Med Sci Sch Hlth Rasht Iran Kermanshah Univ Med Sci Kermanshah Iran Univ Tehran Med Sci Sch Publ Hlth Dept Virol Tehran Iran Khalkhal Univ Med Sci Dept Hlth Informat Technol Khalkhal *** Iran

Introduction Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the incidence of seasonal influenza and other respiratory viral infections. Methods PubMed, Embase, Web of Science, Scopus, Science Direct, Google Scholar, Research Gate, and the World Health Organization databases and websites were systematically searched for original studies concerning the impact of COVID-19 prevention means and measures on other common respiratory infectious diseases during the pandemic published by March 2021. Results The findings showed that the adherence to health protocols to prevent COVID-19 could help to reduce the incidence of other infectious diseases such as influenza, pneumonia, and Mycobacterium tuberculosis. Conclusion The implemented prevention measures and protocols might have reduced the incidence of influenza and some other common respiratory infections. However, controversies exist on this matter and future large population-based studies might provide further information to address these controversies.

关键词： COVID-19 SARS-CoV-2 Infection Prevention

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：